Photo pendingACP-105
Price on application
ACP-105 is a partial agonist SARM developed by Acadia Pharmaceuticals. It displays potent anabolic effects on muscle tissue while exerting minimal activity on the prostate, offering a high degree of tissue selectivity.
Research Profile
ACP-105 is a non-steroidal SARM that functions as a partial agonist at androgen receptors in skeletal muscle and bone tissue. In preclinical models, it has shown anabolic efficacy comparable to testosterone propionate at equivalent doses while producing significantly less prostate stimulation. ACP-105 has been investigated for its potential in treating conditions involving muscle wasting, osteoporosis, and degenerative diseases. Its partial agonist mechanism means it can modulate receptor activity without maximally activating it, which may contribute to its favorable side-effect profile in research settings.
Technical Details
- Chemical Formula
- C16H19ClN2O
- Synonyms
- ACP-105
- Molecular Weight
- 290.79 g/mol
- CAS Number
- 899821-23-9
- Active Ingredient
- 350mg (10mg per capsule)
- Shelf Life
- 36 months